Can a Genetic Test Pick Your Antidepressant? What Pharmacogenomic Testing Can and Can't Tell You

The ads are appealing: a simple cheek swab that tells you which antidepressant will work, so you can skip the trial and error. Patients ask about these tests often, and the honest answer is more interesting than the ads. Pharmacogenomic testing can be useful in specific situations. It just does not do what the marketing implies.

What the Test Actually Measures

Most tests look at genes for liver enzymes, especially CYP2D6 and CYP2C19, that break down many psychiatric medications.

• Slow metabolizers may build up higher blood levels of a medication and have more side effects at standard doses.

• Fast metabolizers may clear a medication before it can work.

• Some panels add "response" genes, such as the serotonin transporter. The evidence for these is much weaker.

Results are usually sorted into colored categories. A medication in the "red" group does not mean you can never take it. Often it means the dose should be adjusted or watched more closely.

What It Cannot Tell You

The test does not tell you which antidepressant will treat your depression. Whether a medication works depends on the right diagnosis, the dose and duration, other conditions, sleep, substance use and what is happening in your life. Genes that affect how fast you clear a drug are one piece of that picture.

What the Research Shows

• The largest trial: the VA's PRIME Care study, published in JAMA in 2022, randomized about 1,900 veterans with depression. When clinicians had test results, they were less likely to prescribe medications with significant predicted gene-drug interactions, and patients had a modest improvement in remission over 24 weeks. The test helped, but it was not a shortcut to recovery.

• Dosing guidance: an international expert group called CPIC publishes guidelines for adjusting certain antidepressants based on CYP2D6 and CYP2C19 results when those results are available.

• FDA labeling: some medication labels already include gene-based guidance. For example, the maximum recommended dose of citalopram is lower for people who are slow CYP2C19 metabolizers.

• Professional guidance: the American Psychiatric Association has not recommended routine testing for everyone starting an antidepressant, and the FDA has warned companies about claims that go beyond the evidence.

When Testing Makes Sense

• You have tried two or more antidepressants and had intolerable side effects at normal doses, or no response at all.

• You seem unusually sensitive to many medications, or unusually resistant to them.

• A medication with gene-specific dosing guidance is being considered.

It is usually less helpful before a first antidepressant, or when cost would be a burden.

Cost, Coverage and Lasting Value

Coverage varies widely. Medicare and some private insurers cover certain tests in specific situations, so check before testing. One advantage is that your genes do not change: a single result can inform future prescriptions, including medications outside psychiatry. The same enzymes affect some pain medications and the blood thinner clopidogrel, which is worth sharing with your other doctors.

Common Questions

Do I need this test before starting an antidepressant? Usually not. Most people do well with a standard, carefully monitored approach.

Will the test tell me whether I have depression? No. It is about how your body processes medications, not about diagnosis.

My current medication shows up as "red." Should I stop it? No. Do not stop a medication based on a test result. Talk with your prescriber, since "red" often means a dose adjustment or closer monitoring rather than a change.

Worth a Conversation

If you have been through several medications without success, or with side effects you could not tolerate, it is reasonable to ask whether testing would help. SANA Psychiatry provides psychiatric evaluation and medication management for adults in Missouri, Illinois and Florida, in person and by video. You can schedule an appointment online.

Written by Sindhura Saini, board-certified psychiatrist (American Board of Psychiatry and Neurology). Last reviewed October 2026. This article is for education and is not a substitute for an individual medical evaluation. Do not stop or change a medication without talking with your prescriber.